Patent details
300407
Product Name:
Tafluprost, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300407
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0850926
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300407
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
1
Marketing Authorization Number:
43230
Marketing Authorization Type:
EEA
Marketing Authorization Date:
30/04/2008
Marketing Authorization Country:
Denmark (DK)
2
Marketing Authorization Number:
RVG 103823
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
03/04/2009
Marketing Authorization Country:
Netherlands (NL)
Dates
Filing date:
02/09/2009
First Marketing Authorization date:
30/04/2008
Grant date:
17/12/2009
Activation date:
22/12/2017
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
02/09/2009
SPC/SPC Extension Expiration Date:
21/12/2022
Lapsed By Expiration Date:
22/12/2022
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
15/08/2018
Name:
AGC Inc.
Address:
1-5-1 Marunouchi
Chiyoda-ku, 100-8405, Tokyo, Japan (JP)
From:
15/08/2018
Name:
SANTEN PHARMACEUTICAL CO., LTD.
Address:
9-19, Shimoshinjo 3-chome, HIGASHIYODOGAWA-KU, OSAKA-SHI, OSAKA 533-8651, Japan (JP)
Historical Applicant/holder
From:
02/09/2009
To:
15/08/2018
Name:
ASAHI GLASS COMPANY LTD.
Address:
1-12-1, Yurakucho 1-chome Chiyoda-ku, 100-8405, Tokyo, Japan (JP)
From:
02/09/2009
To:
15/08/2018
Name:
SANTEN PHARMACEUTICAL CO., LTD.
Address:
9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, 533, Osaka-shi, Osaka, Japan (JP)
Agent
Name:
ir. A. Blokland c.s.
From:
02/09/2009
Address:
Algemeen Octrooi- en Merkenbureau B.V.
Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
51/22
Publication date:
21/12/2022
Description:
Lapse or annulment
2
Bulletin Heading:
CO
Journal edition number:
43/18
Publication date:
17/10/2018
Description:
Changes in the Netherlands Patent Register
3
Bulletin Heading:
SPC
Journal edition number:
52/17
Publication date:
28/12/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
2010/03
Publication date:
01/03/2010
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
Bulletin Heading:
SPC
Journal edition number:
2009/11
Publication date:
02/11/2009
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC201801463B
Date Registered:
15/08/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. A. Blokland c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
1
Name:
SANTEN PHARMACEUTICAL CO., LTD.
Address:
9-19, Shimoshinjo 3-chome, HIGASHIYODOGAWA-KU, OSAKA-SHI, OSAKA 533-8651, Japan (JP)
2
Name:
AGC Inc.
Address:
1-5-1 Marunouchi
Chiyoda-ku, 100-8405, Tokyo, Japan (JP)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
10/12/2021
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Dennemeyer and Co
Filing date
Document type
Document Description
Number of pages
File Type
17/12/2009
SPC Documents
Certificate SPC
1
PDF
/7/0/4/0/0/0400300407/docs/300407_0_supplprotectioncertificate20210218114103000.pdf
17/12/2009
Outgoing Correspondence
Outgoing Letter
1
PDF
/7/0/4/0/0/0400300407/docs/300407_11_outgoingcorrespondence20210218113829079.pdf
04/12/2009
SPC Documents
Marketing Authorization SPC
3
PDF
/7/0/4/0/0/0400300407/docs/300407_2_supplprotectioncertificate20210218112346458.pdf
04/12/2009
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/7/0/4/0/0/0400300407/docs/300407_4_incomingcorrespondencepaper20091204.pdf
04/12/2009
SPC Documents
Summary of the characteristics of the product
7
PDF
/7/0/4/0/0/0400300407/docs/300407_5_supplprotectioncertificate20210218112346527.pdf
24/11/2009
Outgoing Correspondence
Outgoing Letter
1
PDF
/7/0/4/0/0/0400300407/docs/300407_1_outgoingcorrespondence20091124.pdf
23/10/2009
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/7/0/4/0/0/0400300407/docs/300407_6_incomingcorrespondencepaper20210218111745377.pdf
23/10/2009
SPC Documents
Annex SPC
2
PDF
/7/0/4/0/0/0400300407/docs/300407_7_supplprotectioncertificate20210218111901407.pdf
03/09/2009
Outgoing Correspondence
Outgoing Letter
1
PDF
/7/0/4/0/0/0400300407/docs/300407_3_outgoingcorrespondence20090903.pdf
02/09/2009
SPC Documents
Marketing Authorization SPC
1
PDF
/7/0/4/0/0/0400300407/docs/300407_8_supplprotectioncertificate20210218111108718.pdf
02/09/2009
SPC Documents
Accompanying letter SPC
2
PDF
/7/0/4/0/0/0400300407/docs/300407_9_supplprotectioncertificate20210218111543190.pdf
02/09/2009
SPC Documents
SPC Documents
7
PDF
/7/0/4/0/0/0400300407/docs/300407_10_supplprotectioncertificate20210218111244848.pdf
02/09/2009
Application Form
First filed application form
2
PDF
/7/0/4/0/0/0400300407/docs/300407_12_applicationform20090902.pdf